INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
University of Cincinnati
Cincinnati, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Cincinnati (10)
2022
-
Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5
Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 9, pp. 2367-2374.e3
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death
Blood, Vol. 137, Núm. 24, pp. 3351-3364
-
Therapeutic anticoagulation with heparin in noncritically ill patients with covid-19
New England Journal of Medicine, Vol. 385, Núm. 9, pp. 790-802
2016
2012
-
Guidelines for the use and interpretation of assays for monitoring autophagy
Autophagy, Vol. 8, Núm. 4, pp. 445-544
-
International seminar on the red blood cells as vehicles for drugs
Expert Opinion on Biological Therapy
2011
-
Welcome from IAS 2011 chairs
Proceedings of the 2011 7th International Conference on Information Assurance and Security, IAS 2011
-
Welcome message
Proceedings of the 2011 World Congress on Information and Communication Technologies, WICT 2011